[HTML] sciencedirect.com

[HTML][HTML] Management of hyperbilirubinaemia in pancreatic cancer patients

R Álvarez, A Carrato, J Adeva, I Alés, S Prados… - European Journal of …, 2018 - Elsevier
Abstract Development of hyperbilirubinaemia is common in patients with advanced
pancreatic adenocarcinoma, both at diagnosis as well throughout disease evolution. For this …
被引用次数：11 相关文章

Management of hyperbilirubinaemia in pancreatic cancer patients

R Álvarez, A Carrato, J Adeva, I Alés… - European Journal of …, 2018 - ejcancer.com
Abstract Development of hyperbilirubinaemia is common in patients with advanced
pancreatic adenocarcinoma, both at diagnosis as well throughout disease evolution. For this …

Management of hyperbilirubinaemia in pancreatic cancer patients

R Álvarez, A Carrato, J Adeva, I Alés… - … journal of cancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Development of hyperbilirubinaemia is common in patients with advanced pancreatic
adenocarcinoma, both at diagnosis as well throughout disease evolution. For this reason …
[PDF] academia.edu

[PDF][PDF] Management of hyperbilirubinaemia in pancreatic cancer patients

R Alvarez, A Carrato, J Adeva, I Alés… - European Journal of …, 2018 - academia.edu
Abstract Development of hyperbilirubinaemia is common in patients with advanced
pancreatic adenocarcinoma, both at diagnosis as well throughout disease evolution. For this …

Management of hyperbilirubinaemia in pancreatic cancer patients.

R Álvarez, A Carrato, J Adeva, I Alés… - European Journal of …, 2018 - europepmc.org
Development of hyperbilirubinaemia is common in patients with advanced pancreatic
adenocarcinoma, both at diagnosis as well throughout disease evolution. For this reason …